Ivax
Executive Summary
Settles suits with Searle over verapamil extended release tabs Feb. 24. The two firms agreed to drop all claims against each other, including claims by Searle that Ivax' product violated Searle manufacturing process patents for Calan SR. On Dec. 23, Ivax and Knoll similarly settled over Knoll's claims pertaining to its form of verapamil, Isoptin SR